What are the leading stocks in the pharmaceutical biological sector in 2023?

What are the leading stocks in the pharmaceutical biological sector in 2023?

These companies have advantages in the production and sales of R&D and antibiotic drugs, benefiting from the growth of global medical demand and the trend of aging population. The following small series brings the leading stocks of the pharmaceutical biology sector. I hope you like them.

What are the leading stocks in the pharmaceutical biology sector?

Leading stocks in the pharmaceutical industry:

1, Baiyunshan A: According to previous reports, Guangyao Group, the controlling shareholder of Baiyunshan A, and South China New Drug Creation Center and other scientific research institutions announced the launch of major research projects on anti-"superbug" drugs, and will jointly tackle three major research projects: Baiyunshan Banlangen, etc. 10 Research on improving drug resistance of antibacterial and anti-inflammatory Chinese medicines; Screening of combined medication scheme of traditional Chinese medicine and western medicine antibiotics; "Anti-hegemony of Traditional Chinese Medicine in China" New drug research topic However, Baiyun Mountain has previously issued a clarification announcement, indicating that only the first of the three research projects involves the company.

2. Tetracyclic organisms: Influenced by superbugs and domestic ticks, the pharmaceutical sector has been repeatedly hyped, with Lianhuan Pharmaceutical, a smaller sector, as the leader. However, under the supervision of Shenzhen Stock Exchange, the speculation in the pharmaceutical sector showed signs of transfer. In the history of Jiangsu securities and even the history of A-shares, Sihuan creatures have always been quite legendary. The original name of the stock is "Su Sanshan A", and the stock abbreviation has been changed ten times since its listing.

3. Guangzhou Pharmaceutical Industry: Guangzhou Pharmaceutical Group, together with South China New Drug Creation Center and other scientific research institutions, jointly launched the "Guangzhou Pharmaceutical Group's anti-superbug drug research and development project", which will give full play to the advantages of traditional Chinese medicine against "superbugs". Li Chuyuan, general manager of GPHL, announced that GPHL will invest 50 million yuan as the first phase of the project, and South China New Drug Creation Center will also provide matching funds for joint project research.

4. Lianhuan Pharmaceutical: With the help of foreign reports on "super bacteria", the biopharmaceutical sector headed by Lianhuan Pharmaceutical in the early stage was heated by short-term funds. From a fundamental point of view, although the company's performance has been stable in the past two years, it obviously lacks growth and institutional attention. However, the company's announcement has indicated that it is still uncertain whether the company's colistin sulfate tablets are drugs with the same molecular structure as the polymyxin that can inhibit "super bacteria" in media reports.

What leading stocks are there in pharmaceutical manufacturing?

The leading stocks in pharmaceutical manufacturing are: 600085 Tongrentang, 000538 Yunnan Baiyao, 60077 1 Tibet Pharmaceutical, 600285 Ling Rui, 000423 Dong 'e Ejiao, 000650 Renhe Pharmaceutical, 600422 Kunyao, 60077 1 Dongsheng Technology, 000597 Northeast Pharmaceutical. 600488 Tianyao Co., Ltd., 0020 19 Xinfu Pharmaceutical, 600252 Zhongheng Group, 600276 Hengrui Pharma, 000952 Guangji Pharmaceutical, etc.

What are the leading flu medicine stocks?

1, Hengrui Pharma 600276 (Head of Pharmaceutical Unit, Head of Antitumor Drugs)

2. Yunnan Baiyao 000538 (Chinese medicine bibcock)

3. Mindray Medical 300760 (leading medical equipment)

4. Wuxi PharmaTech 603259 (new drug test leader)

5. tonghua dongbao 600867 (diabetes leader)

6. Kelun Pharmaceutical 002422 (large infusion faucet)

7. Xinhecheng 00200 1 (leading vitamin medicine) 8. Renfu Medicine 600079 (leading narcotic)

9. Hualan Bio -002007 (the world's largest influenza vaccine production base and leading plasma producer)

10, Changchun Gaoxin 00066 1 (growth hormone faucet)

1 1, Hua En Pharmaceutical 002262 (central nerve tap)

12, Aier Ophthalmology 3000 15 (head of ophthalmology service)

13, Tongce Medical 600763 (leading dental service)

14, Zheng Qi Tibetan medicine 002287 (plaster sticking medicine faucet)

15, Dongcheng Pharmaceutical 002675 (leading nuclear medicine)

16, Shanghai pharmaceutical 60 1607 (leading pharmaceutical business)

17, TEDA shares 000652 (mask faucet)

18, Yuyue Medical 002223 (faucet of household medical equipment)

19, Dabo Medical 00290 1 (orthopedic material faucet)

20. Lepu Medical 300003 (heart stent faucet)

2 1, Yao Bo 600529 (medical glass faucet)

22. Kangtai Bio 30060 1 (vaccine faucet)

23. Lu Kang Pharmaceutical 600789 (leading antibiotic drug)

24. Tiger Medicine 300347 (clinical CRO faucet)

25. Mei Nian Health 002044 (leading physical examination business)

26. Antu Bio 603658 (chemiluminescence diagnostic reagent faucet)

27. Fan Jian Bio 300529 (faucet of hemoperfusion equipment)

28 Yifeng Pharmacy 603939 (pharmacy leader)

29 five biological -300357 (anti-allergic biological drug faucet)

30. Huada Gene 300676 (leading in genetic testing) 3 1, Zhongyuan Sheikh 600645 (the only stem cell industrialization base in China).

Next, I sorted out 32 low P/E ratios, with earnings per share greater than 0.5 yuan's!

Leading pharmaceutical stocks rank in the top ten.

Pharmaceutical stocks are subdivided into raw materials, chemicals, biological agents, medical services, medical devices, medical services and other fields.

1. API industry: VE, VA leading Xinhecheng, VB5 leading Yifan Pharmaceutical, VB2 leading Guangji Pharmaceutical, VC leading Huabei Pharmaceutical, Northeast Pharmaceutical, VD3 leading Garden Biology, antibiotic APA leading Federal Pharmaceutical and corticosteroid leading Xianju Pharmaceutical.

2. Chemical preparations: Hengrui Pharma, the leading oncology drug, Huahai Pharmaceutical, the leading hypertension drug, China Biopharmaceutical, heparin and Hanyu Pharmaceutical, the leading polypeptide drug.

Biological agents: Li Gan Pharmaceutical Co., Ltd., the third-generation insulin leader, tonghua dongbao, the second-generation insulin leader, Hualan Bio, Kangtai Bio, the leader of blood products (this is controversial and needs to be subdivided), and Fu Honghanlin, the leader of monoclonal antibodies (monoclonal antibodies are scattered and there are many enterprises, Haizheng Bio, Jiahe, etc.). ), growth hormone leader Changchun Gaoxin, antiallergic drug leader Wuwu Bio.

4. Medical services: Aier Ophthalmology, Tongce Medical, Wuxi PharmaTech, Tiger Medicine, Bio-CMO, Yao Ming Bio, independent laboratory leader Jinyu Medicine, and physical examination business leader Mei Nian Health.

Verb (abbreviation of verb) Medical devices: Mindray Medical, the leader of medical device industry chain, Lepu Medical, the leader of heart stent, Wanfu Bio, the leader of household medical devices, Yuyue Medical, Antu Bio, the leader of chemiluminescence diagnostic reagent, and Fan Jian Bio, the leader of hemoperfusion device.

6. Pharmaceutical business: Yifeng Pharmacy, the leading pharmacy, and Sinopharm Holdings, the leading distributor.

Who is the real leader of antibiotics?

At present, domestic listed pharmaceutical companies that can produce tigecycline are Laimei Pharmaceutical (300006), Huabei Pharmaceutical (6008 12) and Haizheng Pharmaceutical (600627). Colistin can be produced by Lianhuan Pharmaceutical (6005 13).

Earlier, some analysts expressed their views on the superbug incident, saying that antibiotics were the main antibiotics. At present, the best antibiotics are tigecycline and vancomycin, commonly known as super antibiotics. Only Haizheng Pharmaceutical (600267) and Zhejiang Pharmaceutical (6002 16) produce and export domestically. However, the published research results did not mention the effectiveness of vancomycin treatment.